Literature DB >> 30085088

Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.

Omar Mansour1,2, Jacqueline Heslin3, Jennifer L Townsend3.   

Abstract

Objectives: Evidence supports the safety and effectiveness of outpatient parenteral antibiotic therapy (OPAT). A registered nurse (RN)-managed multidisciplinary team OPAT model was implemented at our hospital. We evaluated the impact of the new OPAT model on readmissions during OPAT and other core OPAT processes.
Methods: All potential OPAT cases from 1 November 2013 to 31 June 2017 discharged from the Johns Hopkins Bayview Medical Center were followed up in a retrospective cohort study. Relevant clinical and patient characteristics were collected for the first OPAT course per patient. The primary outcome was all-cause readmission to any facility part of the Johns Hopkins Health System within 30 days of OPAT discharge. Proportions of OPAT patients readmitted before and after the implementation of the new OPAT model were compared. A log-binomial regression was used to compare the risk of readmission, adjusted for age, sex, race/ethnicity, site of OPAT care, opioid dependence and OPAT treatment duration.
Results: Five hundred and seventeen OPAT patients were included in the analysis; 51.1% were discharged after the implementation of the new OPAT model. Readmission rates decreased from 20.2% to 13.3% following the RN-managed OPAT programme (P = 0.04). The results of the adjusted model indicated that nurse management was associated with a 39% reduction in the risk of readmission (adjusted relative risk 0.61; 95% CI 0.41-0.91; P = 0.01). Our financial evaluation estimated that the reduction in readmissions achieved by the RN-managed model saved the hospital $649 416 over 15 months. Conclusions: The RN-managed OPAT programme was associated with a significant reduction in readmissions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30085088     DOI: 10.1093/jac/dky294

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder: A nationwide observational study.

Authors:  June-Ho Kim; Danielle R Fine; Lily Li; Simeon D Kimmel; Long H Ngo; Joji Suzuki; Christin N Price; Matthew V Ronan; Shoshana J Herzig
Journal:  PLoS Med       Date:  2020-08-07       Impact factor: 11.069

2.  Recommendations for Systemic Antimicrobial Therapy in Fracture-Related Infection: A Consensus From an International Expert Group.

Authors:  Melissa Depypere; Richard Kuehl; Willem-Jan Metsemakers; Eric Senneville; Martin A McNally; William T Obremskey; Werner Zimmerli; Bridget L Atkins; Andrej Trampuz
Journal:  J Orthop Trauma       Date:  2020-01       Impact factor: 2.884

3.  Patient Experiences With Outpatient Parenteral Antibiotic Therapy: Results of a Patient Survey Comparing Skilled Nursing Facilities and Home Infusion.

Authors:  Omar Mansour; Alicia I Arbaje; Jennifer L Townsend
Journal:  Open Forum Infect Dis       Date:  2019-11-04       Impact factor: 3.835

4.  The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis.

Authors:  Marta Marsilio; Andrea Gramegna; Floriana Fusco; Eleonora Gheduzzi; Giovanna Pizzamiglio; Francesco Blasi; Chiara Guglielmetti
Journal:  Int J Integr Care       Date:  2021-04-30       Impact factor: 5.120

5.  Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.

Authors:  Sabrine Douiyeb; Jara R de la Court; Bram Tuinte; Ferdi Sombogaard; Rogier P Schade; Marianne Kuijvenhoven; Tanca Minderhoud; Kim C E Sigaloff
Journal:  Int J Clin Pharm       Date:  2022-02-14

Review 6.  Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit.

Authors:  Sara Ortonobes; Abel Mujal-Martínez; María de Castro Julve; Alba González-Sánchez; Rafael Jiménez-Pérez; Manuel Hernández-Ávila; Natalia De Alfonso; Ingrid Maye-Pérez; Teresa Valle-Delmás; Alba Rodríguez-Sánchez; Jessica Pino-García; Mònica Gómez-Valent
Journal:  Antibiotics (Basel)       Date:  2022-08-19

7.  Evaluating the safety and effectiveness of a nurse-led outpatient virtual IV vancomycin monitoring clinic: a retrospective cohort study.

Authors:  Kate S Grattan; Mohamed Mohamed Ali; Seyed M Hosseini-Moghaddam; Hayley J I Gilmour; Gregory P Crunican; Erica Hua; Kelly A Muhsin; Rochelle Johnstone; Lise C Bondy; Megan K Devlin; Sarah Shalhoub; Sameer Elsayed; Michael S Silverman
Journal:  JAC Antimicrob Resist       Date:  2021-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.